Metformin Hydrochloride Activase Pharmaceuticals (Metformin Hydrochloride)

Metformin Hydrochloride inhibits mitochondrial complex I in liver cells, which reduces ATP production and activates AMP‑activated protein kinase (AMPK). This cascade suppresses gluconeogenesis, decreases glucose output from the liver, and increases glucose uptake in muscle, thereby lowering overall blood glucose without stimulating insulin release.

The appropriate dose of Metformin Hydrochloride is determined by the prescribing healthcare professional based on individual patient factors such as renal function, glycemic targets, and tolerability. Dosage may be started low and titrated upward, but exact regimens should follow the prescriber’s instructions.

Safety of Metformin Hydrochloride in pregnancy or while breastfeeding should be evaluated by a qualified clinician. It may be prescribed when the potential benefit outweighs any possible risk, but the decision must be individualized and based on current clinical guidelines and patient circumstances.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia compared with sulfonylureas or insulin. Unlike some newer agents, it primarily reduces hepatic glucose output rather than stimulating insulin secretion.

Metformin Hydrochloride should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Metformin Hydrochloride is taken orally, usually with meals to reduce gastrointestinal discomfort. It is available in tablet form and should be swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute medical illness. Other serious concerns include vitamin B12 deficiency and rare severe skin reactions.

Metformin Hydrochloride is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and certain conditions that predispose to lactic acidosis. Clinicians should assess each patient’s medical history before initiating therapy.